Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Hvidovre – page 55

1 426 clinical trials in Hvidovre, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hvidovre at a glance
1 426
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 426 trials in Hvidovre

Open in trial search

Cardiovascular disorder

Not yet recruiting

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Copenhagen University Hospital

Parkinson's disease

Not yet recruiting

Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Levodopa
  • Sponsor:Region Hovedstaden

Plasma cell myeloma refractory+1

Not yet recruiting

Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Elranatamab
  • Sponsor:Region Hovedstaden

Palliative care

Not yet recruiting

Morphine Hydrochloride for Resting Breathlessness in Adults with Serious Chronic Life‑Limiting Disease Receiving Palliative Care

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Skane

Metachromatic leukodystrophy

Not yet recruiting

Long‑Term Monitoring of Malignancy Risk in Early‑Onset Metachromatic Leukodystrophy Patients Treated with atidarsagene autotemcel

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Sponsor:Orchard Therapeutics (Europe) Limited

Interstitial lung disease+2

Not yet recruiting

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Muscular dystrophy

Not yet recruiting

Long-Term Safety and Efficacy of Oral Ribitol in Participants with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I/R9)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Ribitol
  • Sponsor:ML Bio Solutions Inc.

Schizophrenia

Not yet recruiting

Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Rituximab
  • Sponsor:Region Oerebro Laen

Pulmonary embolism

Not yet recruiting

Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Region Hovedstaden

Parkinson's disease

Not yet recruiting

Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Montelukast Sodium
  • Sponsor:Karolinska University Hospital

Cystic fibrosis

Not yet recruiting

Safety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Vertex Pharmaceuticals Inc.

Pancreatitis chronic

Not yet recruiting

Celecoxib versus placebo for pain and quality of life in adult patients with chronic pancreatitis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Celecoxib
  • Sponsor:Odense University Hospital

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hvidovre

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on vaccine development and preventive measures against various infections, including studies on meningococcal vaccines for infants and Group B streptococcus prevention in pregnant women.

  • Meningococcal Infection Prevention
  • Streptococcal Disease Control
  • HIV Prevention Studies

Trials include evaluation of vaccine immunogenicity and safety profiles in different age groups.

02 Maternal and Women's Health

Innovative research addressing maternal mental health and pregnancy-related conditions, with studies focusing on postpartum depression prevention and maternal vaccination strategies.

  • Postpartum Depression Treatment
  • Pregnancy-Related Vaccinations
  • Caesarean Section Pain Management

Clinical investigations emphasize both maternal safety and infant outcomes.

03 Metabolic and Digestive Disorders

Comprehensive studies on inflammatory bowel diseases and metabolic conditions, including innovative treatments for obesity and diabetes management.

  • Crohn's Disease Therapies
  • Ulcerative Colitis Management
  • Weight Management Solutions

Trials evaluate both established and novel therapeutic approaches.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.